VistaPath Biosystems, Inc. — Form D
VistaPath Biosystems, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-07. The offering totals $5.7M, of which $4.4M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-07-07
- Form: D
- Accession: 0001782343-23-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.7M
- Amount sold: $4.4M
- Remaining: $1.2M
- Investors: 5
- Date of first sale: 2023-06-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-486143
Issuer
- Name: VistaPath Biosystems, Inc.
- CIK: 0001782343
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1166 MASSACHUSETTS AVE, CAMBRIDGE, MA, 02139
- Phone: 9173017571
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Benjamin Burley | Director | Cambridge, MA |
| Timothy Spong | Director | Cambridge, MA |
| Benjamin Burley | Executive Officer | Cambridge, MA |
| Timothy Spong | Executive Officer | Cambridge, MA |
| Burley Benjamin | Director | Cambridge, MA |
| Burley Benjamin | Executive Officer | Cambridge, MA |
| Spong Timothy | Director | Cambridge, MA |
| Spong Timothy | Executive Officer | Cambridge, MA |
Other filings by this issuer (7)
More